Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1907588 Target Snapshot

Acetylcholine receptor; alpha1/beta1/delta/gamma · PROTEIN COMPLEX · Homo sapiens

301Compounds
62Assays
3Approved Drugs
265.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P02708. Use UniProt P02708 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P02708 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acetylcholine receptor; alpha1/beta1/delta/gamma as ChEMBL target CHEMBL1907588, mapped to UniProt P02708. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acetylcholine receptor; alpha1/beta1/delta/gamma
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1907588
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P02708
Acetylcholine receptor subunit alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acetylcholine receptor; alpha1/beta1/delta/gamma is the right protein anchor across sources, using UniProt P02708 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAcetylcholine receptor subunit alpha
UniProt AccessionP02708
Component TypeProtein
Sequence Length457 aa

Acetylcholine receptor subunit alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acetylcholine receptor; alpha1/beta1/delta/gamma, mapped to UniProt P02708. ChEMBL maps the protein component as Acetylcholine receptor subunit alpha. Sequence length is 457 aa.

Mapped IDP02708
Review nameAcetylcholine receptor; alpha1/beta1/delta/gamma
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
4
Phase III
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50162.0
KI58.0
EC5045.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL6623 10.28 EC50 0.053 Preclinical
CHEMBL566050 8.82 IC50 1.5 Preclinical
CHEMBL569465 8.7 IC50 2.0 Preclinical
CHEMBL566208 8.57 IC50 2.7 Preclinical
CHEMBL566886 8.41 IC50 3.9 Preclinical
CHEMBL565844 8.24 IC50 5.7 Preclinical
CHEMBL592854 8.24 IC50 5.8 Preclinical
CHEMBL599846 8.19 IC50 6.5 Preclinical
CHEMBL566001 8.12 IC50 7.6 Preclinical
CHEMBL589250 8.04 IC50 9.2 Preclinical
Distribution

pChEMBL Value Distribution

32
5.0
6
5.5
6
6.0
4
6.5
6
7.0
17
7.5
8
8.0
3
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

62
Total Assays
92
Tested Compounds
2
Assay Types
Binding — 33 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 16 11 5.6
protein complex format 14 15 5.6
cell membrane format 2 1 5.4
tissue-based format 1 0
Functional — 29 assays, 92 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 25 91 5.9
assay format 4 1 4.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine